Q2 2026 Holdings
Filed 2026-08-13 | 99 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| United Health Group Inc(UNH) | COM | 91324P102 | $38.9M | 93,600 | 3.7% |
| CVS Health Corp(CVS) | COM | 126650100 | $28.9M | 279,374 | 2.7% |
| Astrazeneca PLC(AZN) | ORD | G0593M107 | $28.5M | 151,500 | 2.7% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $27.4M | 213,500 | 2.6% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $26.8M | 22,315 | 2.5% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $24.4M | 96,775 | 2.3% |
| Alignment Healthcare Inc(ALHC) | COM | 01625V104 | $23.7M | 997,083 | 2.2% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $23.5M | 260,000 | 2.2% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $22.5M | 178,250 | 2.1% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $21.1M | 87,440 | 2.0% |
| Biogen Inc(BIIB) | COM | 09062X103 | $20.5M | 94,850 | 1.9% |
| Stryker Corporation(SYK) | COM | 863667101 | $20.5M | 65,000 | 1.9% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $19.2M | 450,500 | 1.8% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $18.4M | 72,500 | 1.7% |
| Guardant Health Inc(GH) | COM | 40131M109 | $17.3M | 115,000 | 1.6% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $17.1M | 27,390 | 1.6% |
| Glaukos Corp(GKOS) | COM | 377322102 | $16.6M | 119,000 | 1.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $16.6M | 290,500 | 1.6% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $16.6M | 684,250 | 1.6% |
| Natera Inc(NTRA) | COM | 632307104 | $16.6M | 61,050 | 1.6% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $16.3M | 139,205 | 1.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $16.2M | 151,960 | 1.5% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $15.9M | 85,200 | 1.5% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $15.8M | 31,580 | 1.5% |
| Centene Corp del(CNC) | COM | 15135B101 | $15.7M | 244,000 | 1.5% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $15.4M | 63,050 | 1.5% |
| Danaher Corporation(DHR) | COM | 235851102 | $15.3M | 80,252 | 1.4% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $15.2M | 30,685 | 1.4% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $15.2M | 1,538,625 | 1.4% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $14.5M | 85,841 | 1.4% |
| Pennant Group Inc(PNTG) | COM | 70805E109 | $13.7M | 371,471 | 1.3% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $13.7M | 34,500 | 1.3% |
| Elevance Health Inc(ELV) | COM | 036752103 | $13.5M | 34,900 | 1.3% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $13.5M | 164,000 | 1.3% |
| Cencora Inc(COR) | COM | 03073E105 | $13.2M | 46,778 | 1.2% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $13.0M | 57,200 | 1.2% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $12.8M | 343,800 | 1.2% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $12.5M | 16,550 | 1.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $12.2M | 560,250 | 1.2% |
| Brightspring Health Svcs Inc(BTSG) | COM | 10950A106 | $11.6M | 165,896 | 1.1% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $11.3M | 145,000 | 1.1% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $11.2M | 416,371 | 1.1% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $11.2M | 392,000 | 1.1% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $11.0M | 197,000 | 1.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $10.8M | 160,000 | 1.0% |
| Align Technology Inc(ALGN) | COM | 016255101 | $10.6M | 63,000 | 1.0% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $10.6M | 119,300 | 1.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $10.6M | 566,000 | 1.0% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $10.4M | 128,000 | 1.0% |
| Agilent Technologies Inc(A) | COM | 00846U101 | $10.0M | 75,000 | 0.9% |